Počet záznamov: 1
MiR-21-5P enhances the progression and paclitaxel resistance in druh-resistant breast cancer cell lines by targeting PDCD4
SYS 0160718 LBL 00000naa^^22^^^^^^^^450 005 20191115143830.2 100 $a 20191115d2019 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a MiR-21-5P enhances the progression and paclitaxel resistance in druh-resistant breast cancer cell lines by targeting PDCD4 $f L. Tao, Y. Q. Wu, S. P. Zhang 215 $c ilustr., grafy, schéma 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0160615 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 66, no. 5 (2019), s. 746-755 $1 210 $a Bratislava $c AEPress $d 2019 $1 215 $a s. 671-857 700 -1
$3 sllk_un_auth*0050338 $a Tao $b L. $4 070 701 -1
$3 sllk_un_auth*0050339 $a Wu $b Y. Q. $4 070 701 -1
$3 sllk_un_auth*0050340 $a Zhang $b S. P. $4 070 801 -0
$a SK $b BA006 $c 20191115 $g AACR2
Počet záznamov: 1